Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study

<b>Background:</b> With advances in antiretroviral therapy for HIV treatment, newer drug combinations provide improved efficacy, safety, and compliance. This study evaluates switching to a regimen of doravirine (DOR), tenofovir disoproxil fumarate (TDF), and lamivudine (3TC) in a cohort of people li...

Cijeli opis

Bibliografski detalji

Glavni autori:	Stefania Cicalini, Simone Lanini, Roberta Gagliardini, Rita Bellagamba, Alessandra Vergori, Ilaria Mastrorosa, Valentina Mazzotta, Rozenn Esvan, Maria Maddalena Plazzi, Sandrine Ottou, Elisabetta Grilli, Federico De Zottis, Marisa Fusto, Jessica Paulicelli, Andrea Antinori
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2024-12-01
Serija:	Pharmaceuticals
Teme:	non-nucleoside reverse transcriptase inhibitors (NNRTIs) antiretroviral therapy optimization single tablet regimen (STR)
Online pristup:	https://www.mdpi.com/1424-8247/17/12/1706
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!